Terms: = Endocrine gland cancer AND TCF7L2, ENSG00000148737, 6934, TCF-4 AND Prognosis
3 results:
1. Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid cancer Invasion.
Nicolson NG; Paulsson JO; Juhlin CC; Carling T; Korah R
Endocr Pathol; 2020 Dec; 31(4):367-376. PubMed ID: 33063251
[TBL] [Abstract] [Full Text] [Related]
2. The Wnt3a/β-catenin/tcf7l2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab.
Shen G; Gao Q; Liu F; Zhang Y; Dai M; Zhao T; Cheng M; Xu T; Jin P; Yin W; Huang D; Weng H; Chen W; Ren H; Mu X; Wu X; Hu S
Biochem Biophys Res Commun; 2020 Jun; 526(3):685-691. PubMed ID: 32248976
[TBL] [Abstract] [Full Text] [Related]
3. tcf7l2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer.
Xiang J; Hu Q; Qin Y; Ji S; Xu W; Liu W; Shi S; Liang C; Liu J; Meng Q; Liang D; Ni Q; Xu J; Zhang B; Yu X
Cell Death Dis; 2018 Feb; 9(3):321. PubMed ID: 29476053
[TBL] [Abstract] [Full Text] [Related]
